(MedPage Today) — An investigational GLP-1 receptor agonist pill edged out oral semaglutide (Rybelsus) for improving blood glucose in adults with type 2 diabetes inadequately controlled on metformin, the phase III ACHIEVE-3 trial showed.
Among…
Source link : https://www.medpagetoday.com/endocrinology/diabetes/120066
Author :
Publish date : 2026-02-26 20:40:00
Copyright for syndicated content belongs to the linked Source.
